Fuji Pharma Co.,Ltd.

4554・Prime Market・Pharmaceuticals

Official website

Fuji Pharma Co.,Ltd.

4554・Prime Market・Pharmaceuticals

Official website

Fuji Pharma Co.,Ltd.4554

Reference Indicators

Market Cap

506¥100M

P/E (Forecast)

20.8x

P/B

1.0x

Dividend Yield (Forecast)

2.57%

ROE

6.5%

EV/EBITDA

7.8x

Financial Summary

Unit: ¥M

Item	2021Sep 2021	2022Sep 2022	2023Sep 2023	2024Sep 2024	2025Sep 2025
Net Sales	33,990	35,426	40,889	46,138	51,677
Cost of Sales	19,239	20,867	24,374	28,294	30,914
Gross Profit	14,751	14,558	16,514	17,844	20,763
SG&A Expenses	11,402	10,781	12,656	13,963	15,773
Operating Income	3,349	3,777	3,858	3,880	4,990
Non-operating Income	30	330	790	812	187
Non-operating Expenses	129	382	129	247	718
Ordinary Income	3,250	3,725	4,519	4,445	4,459
Extraordinary Income	155	—	—	3,953	—
Extraordinary Losses	34	1	120	123	458
Pre-tax Income	3,371	3,723	4,399	8,276	4,000
Income Taxes	938	1,026	963	2,128	1,000
Net Income	2,432	2,696	3,435	6,146	3,000
EBITDA	5,455	6,522	6,881	7,560	8,955
Gross Margin	43.4%	41.1%	40.4%	38.7%	40.2%
Operating Margin	9.9%	10.7%	9.4%	8.4%	9.7%
ROA	3.8%	3.6%	4.0%	6.8%	3.2%
ROE	6.7%	7.9%	8.9%	14.2%	6.5%